Alexander Ullrich von Gabain
Chairman at Eit Health eV
Network origin in Alexander Ullrich von Gabain first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
21
| Extinct | Pharmaceuticals: Major | 21 |
European Institute of Innovation & Technology
7
| College/University | Other Consumer Services | 7 |
Karolinska Institutet
6
| College/University | Other Consumer Services | 6 |
Eit Health eV
 Eit Health eV Medical/Nursing ServicesHealth Services Eit Health eV is a network of health innovators supported by the EU. The private company is based in Munich, Germany, and has subsidiaries in Spain. The German company collaborates across borders to provide new solutions that can help European citizens live longer and healthier lives. The company connects all relevant healthcare players across European borders, including research, education, and business, to bring innovative healthcare solutions to the market. The CEO of the company is Jan-Philipp Beck.
3
| Private Company | Medical/Nursing Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexander Ullrich von Gabain via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| IOMAI CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| HOOKIPA PHARMA INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer Public Communications Contact Founder | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Chief Operating Officer Director/Board Member | |
| Valneva USA, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer | ||
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President Director/Board Member | |
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member Director/Board Member | |
| Intercell Austria AG | Corporate Officer/Principal Chief Executive Officer | ||
| Vivalis Toyama Japan KK | Chairman Director/Board Member | ||
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree | |
| Smol Therapeutics SAS | Chief Executive Officer Chairman | ||
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member Director/Board Member | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Chief Executive Officer | |
| University of Vienna | College/University | Doctorate Degree Graduate Degree | |
| EXICURE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
| Harvard Business School | College/University | Graduate Degree Masters Business Admin | |
| The University of Waterloo | College/University | Graduate Degree Undergraduate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Sales & Marketing Director of Finance/CFO | |
| University of Milan | College/University | Undergraduate Degree Corporate Officer/Principal | |
| European Round Table of Industrialists | Chairman Corporate Officer/Principal | ||
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree | |
Biovertis AG
 Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Chairman | |
| University of Strasbourg | College/University | Doctorate Degree Doctorate Degree | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Operating Officer | |
| CEGEDIM | Packaged Software | Director/Board Member | |
Altrad Investment Authority SAS
 Altrad Investment Authority SAS Trucks/Construction/Farm MachineryProducer Manufacturing Altrad Investment Authority SAS provides industrial services. It offers services to oil, gas, energy, power generation, process environment, and construction sectors. The company was founded by Mohed Altrad in 1985 and is headquartered in Montpellier, France. | Trucks/Construction/Farm Machinery | Director/Board Member | |
Cylande SA
 Cylande SA Packaged SoftwareTechnology Services Cylande SA offers software publishing, engineering and distribution services. The firm provides software for vertical enterprise resource planning solutions designed specifically for specialized stores and mass distribution such as hypermarkets, supermarkets, large and average surface stores, corner stores, superstores, boutiques, and specialized surface stores. The company was founded by Jean Pierre Paugam in 1986 and is headquartered in Roubaix, France. | Packaged Software | Director/Board Member | |
ISORG SA
 ISORG SA Electronics DistributorsDistribution Services ISORG SA offers organic and printed electronics devices for large-area photonics and image sensors. Its products include photo detectors and sensors for inventory control and warehouse management. The company was founded by Jean-Yves Gomez, Emmanuel Guerineau and Laurent Jamet in 2010 and is headquartered in Grenoble, France. | Electronics Distributors | Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Analyst | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member | |
Tinubu Square SA
 Tinubu Square SA Packaged SoftwareTechnology Services Tinubu Square SA develops and publishes software as service (SaaS) applications. It offers solutions for credit insurance, receivable financing, risk management center, risk analyst, credit intelligence, debt collection, and claims management. The company was founded by J?r?me Pez? and Olivier Placca in 2000 and is headquartered in Issy-les-Moulineaux, France. | Packaged Software | Director/Board Member |
Statistics
International
| France | 13 |
| United States | 10 |
| United Kingdom | 8 |
| Austria | 7 |
| Sweden | 6 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Finance | 4 |
| Technology Services | 4 |
Operational
| Director/Board Member | 405 |
| Corporate Officer/Principal | 115 |
| Chairman | 106 |
| Independent Dir/Board Member | 79 |
| Chief Executive Officer | 54 |
Most connected contacts
- Stock Market
- Insiders
- Alexander Ullrich von Gabain
- Company connections
